Anthrax is an acute disease caused by the bacterium Bacillus anthracis. Most forms of the disease are lethal, and it affects both humans and other animals. There are effective vaccines against anthrax, and some forms of the disease respond well to antibiotic treatment.
Continue reading ‘Antibiotics – A Possible Cure for Anthrax?’
Thalidomide was introduced as a sedative drug in the late 1950s. In 1961, it was withdrawn due to teratogenicity and neuropathy. There is now a growing clinical interest in thalidomide, and it is introduced as an immunomodulatory agent used primarily, combined with dexamethasone, to treat multiple myeloma. The drug is a potent teratogen in zebrafish, chickens, rabbits and primates including humans: severe birth defects may result if the drug is taken during pregnancy.
Continue reading ‘Researchers Gain More Insight on How Thalidomide Leads to Birth Defects’
New research has indicated that people who are exposed to very low levels of sunlight and who also have a history of having a common virus known as mononucleosis, are at greater odds of developing multiple sclerosis (MS) than those without the virus.
Continue reading ‘Low Sunlight Exposure and Common Virus Responsible for Multiple Sclerosis’
A researching team from the University of Leicester has offered the promise of a simple injection that could be developed to restrict the damage that results from heart attacks and strokes. Described by the lead researcher as ‘a fascinating new achievement’, work has already begun to translate the research into novel clinical therapies.
Continue reading ‘Preventing Damage from Heart Attacks & Strokes with an Injection’
By combining nanotechnology and medical research, Sandia National Laboratories, the University of New Mexico, and the UNM Cancer Research and Treatment Center, have successfully been able to produce a highly efficient strategy that makes use of nanoparticles to kill cancerous cells with a wide variety of drugs.
If you thought that you are a person who craves coffee more than others, then now is the time to explore your genetics, as scientist have proven that caffeine addiction is part of our DNA. According to a report, there are differences in two genes which cause people to consume more or less caffeine. Individuals who have a “high-consumption” variation of either gene appear to drink more coffee, as compared to those who have a “low-consumption” variant.
New research has shown that nasal vaccines are much more effective in providing protection against the flu. In fact the research also proved that nasal vaccines will soon protect not only against the flu and pneumonia, but also against bioterrorism agents such as Yersinia pestis that causes the plague. The research, presented at the Society for General Microbiology’s Spring Conference in Harrogate, presented Professor Dennis Metzger who described how including a natural immune chemical with standard vaccines has the potential to increase their protective impact when delivered through the nose.
Continue reading ‘Nasal Spray Vaccines More Effective against Flu’
Recent research has shown that the cause of Sudden Infant Death Syndrome (SIDS) is likely to be in the brain. SIDS is yet to be understood by scientists properly and the condition is also known as ‘cot death’. The new research conducted by the Macquarie University in Sydney looks at particular regions of the brain and how they communicate to control breathing. The study builds on earlier studies that suspected abnormalities in the brain could be the cause for SIDS. It is hoped that this research may improve the understanding of this condition.
Continue reading ‘Causes of Sudden Infant Death Syndrome Likely in the Brain’
In what could be the biggest breakthrough in the treatment of one of the deadliest cancer types, researchers at the University of East Anglia (UEA) and Children’s Hospital Boston have unveiled an effective new treatment for treating melanoma skin cancer.
Continue reading ‘Arthritis Drug to Combat Melanoma Skin Cancer’
New scientific research published by the American Heart Association has indicated that doctors are motivated to turn towards therapeutic treatments along with blood thinners to relieve patients suffering from fatal blood clots found in deep veins that ultimately travel to the lungs.
Continue reading ‘New Research to Help in Treating Fatal Blood Clots’
You are currently browsing the weblog archives for the Healthcare category.
Biotech Trading Signals Pharma News Biotech News